Re: Farmas USA
Ahora resulta que el salvador del sector es una nota de un viejo conocido de NVAX...Edward Tenthoff de Piper! jajaja
Biotech Bounces Back; M&A Eyed
http://www.streetinsider.com/Analyst+Comments/Biotech+Bounces+Back%3B+M%26A+Eyed/11220353.html
y la parte de nvax para los más vagos,
While Tenthoff didn't get too specific on targets he did highlight his top pick Novavax (NASDAQ: NVAX), which has Phase III elderly RSV data this fall. "Recent pull back in share price and/or positive Phase III RSV data could draw multiple take out bids from larger vaccine players," he said.
El mismo que tiró la cotización, ahora la pumpea como candidata a buyout...
NVAX